Literature DB >> 1141956

The ultrastruct of normal human muscle in relation to fibre type.

M J Cullen, D Weightman.   

Abstract

A quantitative analysis using a stereological point-counting method was made of the volume fractions of the components of healthy human muscle in an attempt to distinguish between Type I and Type II fibres ultrastructurally. The Z-line widths of each fibre were also measured using the 38.5 nm axial periodicity in the I-band as a reference measurement. There was a wide range of values for the parameters measured. The volume of mitochondria was 5.14 plus or minus 1.85% (mean plus or minus standard deviation, n=24 fibres), the volume of the membrane systems was 1.59 plus or minus 0.31%, the volume of the sarcoplasm was 9.37 plus or minus 2.50% and the volume of lipid was 0.63 plus or minus 0.43%. The width of the Z-lines was 89.0 plus or minus 18.65 nm. The results show that no single feature can be used to distinguish fibre types reliably. If 2 factors are measured and certain assumptions are made, it is possible to classify about 50% of the fibres examined. These conclusions are discussed in relation to other workers' findings on the effects of age, sex and athleticism on the ultrastructure of muscle.

Entities:  

Mesh:

Year:  1975        PMID: 1141956     DOI: 10.1016/0022-510x(75)90185-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Tubular aggregates: their association with myalgia.

Authors:  E Niakan; Y Harati; M J Danon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

2.  Stereological analyses of the structure of mitochondria in pigeon skeletal muscle.

Authors:  N T James; G A Meek
Journal:  Cell Tissue Res       Date:  1979-11       Impact factor: 5.249

3.  A comparative study of the transverse tubular system of the rat extensor digitorum longus and soleus muscles.

Authors:  M J Cullen; S Hollingworth; M W Marshall
Journal:  J Anat       Date:  1984-03       Impact factor: 2.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.